Health & Fitness
Health and Fitness
Health and Fitness
Wed, February 25, 2009
Tue, February 24, 2009 Celsion to Hold Fourth Quarter and Fiscal 2008 Financial Results Call Tuesday, March 3, 2009
COLUMBIA, Md.--([ BUSINESS WIRE ])--Celsion Corporation (NASDAQ: CLSN), a biotechnology drug development company that is leveraging its Heat Sensitive Liposomal Technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics,today announced that it would hold a conference call to discuss fourth quarter and fiscal 2008 results at 11:00 a.m. Eastern Time on Tuesday, March 3, 2009. To participate in the call, interested parties may dial 877-604-2080 (U.S./Canada) or 706-902-1383 (International) and use Conference ID: #87627643 to register ten minutes before the call is scheduled to begin. The call will also be broadcast live on the Internet at [ http://www.celsion.com ].
The call will be archived for replay on March 3, 2009 at 2:00 P.M. and will remain available until Monday, March 9, 2009. The replay can be accessed at 800-642-1687 or 706-645-9291 using Conference ID: #87627643. The call will also be available on the Company's website, [ http://www.celsion.com ], for 30 days after 2:00 p.m. on Tuesday, March 3, 2009.
About Celsion
Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic, North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: [ http://www.celsion.com ].
